IP Verse

Beigene competitive analysis

Loading summary...

Latest patents of Beigene opposed by its competitors

Explore Beigene's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3500299
Dec 13, 2023Use Of A Combination Comprising A Btk Inhibitor For Treating Cancers2

Latest publications and patents of Beigene New

Explore the latest publications and patents granted to Beigene, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Beigene

EP3500299
Dec 13, 2023Use Of A Combination Comprising A Btk Inhibitor For Treating CancersGranted And Under Opposition
EP3013797
Jan 3, 2018Fused Tricyclic Amide Compounds As Multiple Kinase InhibitorsNo Opposition Filed Within Time Limit

Latest PTAB cases involving Beigene

Discover the latest PTAB cases involving Beigene, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 27, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Beigene

PGR2024-00009Nov 1, 2023BEIGENE USAPHARMACYCLICSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Beigene with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BEIGENE - 2 - -
KERNEBECK PATENTANWALTS1 - - -
TEVA PHARMACEUTICALS20916 - 12